Coughlin Timothy

CIK 00013760436 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001376043

Recent Transactions

50 trades

Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-06-12$26.52/sh+10,000→ 66,250 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-06-12$50.07/sh−10,000→ 56,250 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Stock Option (Right to Buy)
2026-06-12−10,000→ 0 total
Award
Vir Biotechnology, Inc.$VIR
Common Stock
2026-06-09+8,000→ 8,000 total
Award
Vir Biotechnology, Inc.$VIR
Common Stock
2026-06-09+8,000→ 16,000 total
Award
Vir Biotechnology, Inc.$VIR
Stock Option (Right to Buy)
2026-06-09+16,000→ 16,000 total
Award
Vir Biotechnology, Inc.$VIR
Stock Option (Right to Buy)
2026-06-09+16,000→ 16,000 total
Tax Payment
ADC Therapeutics SA$ADCT
Common Shares
2026-06-03$3.08/sh−12,600→ 72,400 total
Award
ADC Therapeutics SA$ADCT
Common Shares
2026-06-01+45,000→ 85,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-19+4,000→ 56,250 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-05-19+12,000→ 12,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-15$43.49/sh−3,250→ 52,250 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2026-05-11+50,000→ 50,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Director stock option (right to buy)
2025-10-31−8,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Director stock option (right to buy)
2025-10-31−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-31$17.44/sh+10,000→ 73,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-31$16.33/sh+8,000→ 63,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-31$35.03/sh−18,000→ 55,500 total
Award
ADC Therapeutics SA$ADCT
Stock Options (Right to Buy)
2025-06-03+80,000→ 80,000 total
Award
ADC Therapeutics SA$ADCT
Common Shares
2025-06-03+40,000→ 40,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-15+6,500→ 55,500 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2025-05-15+19,500→ 19,500 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2025-05-01+50,000→ 50,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2024-06-07+40,000→ 40,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2024-05-30$1.75/sh+50,000→ 56,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2024-05-22+24,000→ 24,000 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2024-05-08+19,500→ 19,500 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-05-08+6,500→ 49,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-06-06+40,000→ 40,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2023-05-17+12,000→ 12,000 total
Gift
aTYR PHARMA INC$ATYR
Common Stock
2023-05-17+6,000→ 6,000 total
Gift
aTYR PHARMA INC$ATYR
Common Stock
2023-05-17−6,000→ 0 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-05-17+4,500→ 42,500 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2023-05-17+13,500→ 13,500 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Restricted Stock Unit
2023-04-26−6,000→ 0 total
Exercise/Conversion
aTYR PHARMA INC$ATYR
Common stock
2023-04-26+6,000→ 6,000 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-09+8,650→ 9,892 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2022-06-09+11,893→ 11,893 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-03$22.81/sh−1,439→ 57,632 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-05-11+3,000→ 38,000 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2022-05-11+9,000→ 9,000 total
Award
aTYR PHARMA INC$ATYR
Restricted Stock Units
2022-04-26+6,000→ 6,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2021-06-02+4,334→ 4,334 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2021-06-02+2,681→ 59,071 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-05-14+3,000→ 35,000 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2021-05-14+9,000→ 9,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2021-04-28+1,428→ 1,428 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2020-05-15+3,000→ 32,000 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2020-05-15+9,000→ 9,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2020-05-06+1,428→ 1,428 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov